Neoadjuvant Model as a Platform for Research in Breast Cancer and Novel Targets under Development in this Field.

Escrivá-de-Romaní, Santiago; Arumí, Miriam; Zamora, Esther; Bellet, Meritxell

Escrivá-de-Romaní, Santiago; Arumí, Miriam; Zamora, Esther; Bellet, Meritxell.

Afiliação

Escrivá-de-Romaní S; Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Arumí M; Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Zamora E; Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Bellet M; Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Breast Care (Basel) ; 13(4): 251-262, 2018 Aug.

Article em En | MEDLINE | ID: mdl-30319327

Palavras-chave

Biomarker; Breast cancer; Chemotherapy; Endocrine therapy; Neoadjuvant; Translational research

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google